Search

everythinglearnresearchcommunity

for

Search:↓

The woman was diagnosed with Vogt–Koyanagi–Harada disease and successfully treated with medication, restoring her vision and stopping headaches.

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

Bimatoprost effectively enhances eyelash growth but may not work for all eyelash loss conditions.

Hair follicle stem cells can become corneal-like cells with the right environment.

Corn silage alone is not a balanced diet for buffalo calves.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

A cat with skin bumps and itching had high blood fats and skin infections, which improved with diet and medication changes.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

AS-OCT is crucial for diagnosing VZV interstitial keratitis and avoiding unnecessary treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

CMV infection increases the risk of GvHD after bone marrow transplants.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Occipital donor sites for skin grafts heal faster, hurt less, look better, and have fewer complications than femoral sites.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Vogt-Koyanagi syndrome often leads to partial or complete blindness and responds poorly to treatment.